NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its third quarter revenues rose 74 percent year over year, thanks largely to a 105 percent increase in testing services revenues.

For the three months ended Sept. 30, the diagnostics company said revenues rose to $21.2 million from $12.2 million in Q3 2017, beating analysts' average estimate of $18.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.